{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T05:47:44Z","timestamp":1782366464859,"version":"3.54.5"},"reference-count":35,"publisher":"Centers for Disease Control and Prevention (CDC)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Emerg. Infect. Dis."],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.3201\/eid2206.151709","type":"journal-article","created":{"date-parts":[[2016,4,25]],"date-time":"2016-04-25T17:56:50Z","timestamp":1461607010000},"page":"1057-1066","source":"Crossref","is-referenced-by-count":25,"title":["High MICs for Vancomycin and Daptomycin and Complicated Catheter-Related Bloodstream Infections with Methicillin-Sensitive<i>Staphylococcus aureus<\/i>"],"prefix":"10.3201","volume":"22","author":[{"given":"Rafael","family":"San-Juan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Viedma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Chaves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Lalueza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"Fort\u00fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Loza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miquel","family":"Pujol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Ardanuy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Morales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"de Cueto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Resino-Foz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandra","family":"Morales-Cartagena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Rico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda P.","family":"Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda \u00c1ngeles","family":"Orellana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"L\u00f3pez-Medrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Fern\u00e1ndez-Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Mar\u00eda","family":"Aguado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1822","reference":[{"key":"key-10.3201\/eid2206.151709-201605110930-R1","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1136\/bmj.38834.421713.2F","article-title":"Mortality after Staphylococcus aureus bacteraemia in two hospitals in Oxfordshire, 1997\u20132003: cohort study.","volume":"333","author":"Wyllie","year":"2006","journal-title":"BMJ"},{"key":"key-10.3201\/eid2206.151709-201605110930-R2","doi-asserted-by":"publisher","first-page":"3315","DOI":"10.1128\/AAC.00113-08","article-title":"Relationship between vancomycin MIC and failure among patients with methicillin-resistant Staphylococcus aureus bacteremia treated with vancomycin.","volume":"52","author":"Lodise","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.3201\/eid2206.151709-201605110930-R3","doi-asserted-by":"publisher","first-page":"2582","DOI":"10.1128\/AAC.00939-06","article-title":"Vancomycin in vitro bactericidal activity and its relationship to efficacy in clearance of methicillin-resistant Staphylococcus aureus bacteremia.","volume":"51","author":"Moise","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.3201\/eid2206.151709-201605110930-R4","doi-asserted-by":"publisher","first-page":"2398","DOI":"10.1128\/JCM.42.6.2398-2402.2004","article-title":"Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia.","volume":"42","author":"Sakoulas","year":"2004","journal-title":"J Clin Microbiol"},{"key":"key-10.3201\/eid2206.151709-201605110930-R5","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1086\/524667","article-title":"Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia.","volume":"46","author":"Soriano","year":"2008","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid2206.151709-201605110930-R6","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1093\/cid\/cir935","article-title":"The clinical significance of vancomycin minimum inhibitory concentration in Staphylococcus aureus infections: a systematic review and meta-analysis.","volume":"54","author":"van Hal","year":"2012","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid2206.151709-201605110930-R7","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1093\/infdis\/jir270","article-title":"Antibiotic choice may not explain poorer outcomes in patients with Staphylococcus aureus bacteremia and high vancomycin minimum inhibitory concentrations.","volume":"204","author":"Holmes","year":"2011","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid2206.151709-201605110930-R8","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1093\/cid\/ciu183","article-title":"Effect of vancomycin minimal inhibitory concentration on the outcome of methicillin-susceptible Staphylococcus aureus endocarditis.","volume":"58","author":"Cervera","year":"2014","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid2206.151709-201605110930-R9","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1111\/1469-0691.12108","article-title":"Predictive factors for mortality in patients with methicillin-resistant Staphylococcus aureus bloodstream infection: impact on outcome of host, microorganism and therapy.","volume":"19","author":"Gasch","year":"2013","journal-title":"Clin Microbiol Infect"},{"key":"key-10.3201\/eid2206.151709-201605110930-R10","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1086\/649572","article-title":"Is high vancomycin minimum inhibitory concentration a good marker to predict the outcome of methicillin-resistant Staphylococcus aureus bacteremia?","volume":"201","author":"Lalueza","year":"2010","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid2206.151709-201605110930-R11","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1093\/jac\/dks128","article-title":"Vancomycin MICs do not predict the outcome of methicillin-resistant Staphylococcus aureus bloodstream infections in correctly treated patients.","volume":"67","author":"Rojas","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"key-10.3201\/eid2206.151709-201605110930-R12","doi-asserted-by":"publisher","first-page":"2652","DOI":"10.1093\/jac\/dkv133","article-title":"Is reduced vancomycin susceptibility a factor associated with poor prognosis in MSSA bacteraemia?","volume":"70","author":"L\u00f3pez-Cort\u00e9s","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"key-10.3201\/eid2206.151709-201605110930-R13","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.3201\/eid\/1706.101037","article-title":"High vancomycin MIC and complicated methicillin-susceptible Staphylococcus aureus bacteremia.","volume":"17","author":"Aguado","year":"2011","journal-title":"Emerg Infect Dis"},{"key":"key-10.3201\/eid2206.151709-201605110930-R14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1086\/599376","article-title":"Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America.","volume":"49","author":"Mermel","year":"2009","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid2206.151709-201605110930-R15","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/0021-9681(87)90107-X","article-title":"Morbidity during hospitalization: can we predict it?","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"key-10.3201\/eid2206.151709-201605110930-R16","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1097\/00000441-196012000-00010","article-title":"Treatment of chronic pyelonephritis. III. Comparison of several drugs combined and one member of the combination, colistin.","volume":"240","author":"McCabe","year":"1960","journal-title":"Am J Med Sci"},{"key":"key-10.3201\/eid2206.151709-201605110930-R17","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/S0924-8579(98)00060-0","article-title":"Combination antibiotic therapy versus monotherapy for gram-negative bacteraemia: a commentary.","volume":"11","author":"Chow","year":"1999","journal-title":"Int J Antimicrob Agents"},{"key":"key-10.3201\/eid2206.151709-201605110930-R18","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/0002-9343(94)90143-0","article-title":"New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service.","volume":"96","author":"Durack","year":"1994","journal-title":"Am J Med"},{"key":"key-10.3201\/eid2206.151709-201605110930-R19","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1001\/archinte.163.17.2066","article-title":"Clinical identifiers of complicated Staphylococcus aureus bacteremia.","volume":"163","author":"Fowler","year":"2003","journal-title":"Arch Intern Med"},{"key":"key-10.3201\/eid2206.151709-201605110930-R20","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1128\/JCM.39.7.2439-2444.2001","article-title":"Evaluation of current methods for detection of staphylococci with reduced susceptibility to glycopeptides.","volume":"39","author":"Walsh","year":"2001","journal-title":"J Clin Microbiol"},{"key":"key-10.3201\/eid2206.151709-201605110930-R21","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1128\/AAC.50.4.1581-1585.2006","article-title":"Induction of daptomycin heterogeneous susceptibility in Staphylococcus aureus by exposure to vancomycin.","volume":"50","author":"Sakoulas","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.3201\/eid2206.151709-201605110930-R22","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1128\/AAC.50.3.1079-1082.2006","article-title":"Correlation between reduced daptomycin susceptibility and vancomycin resistance in vancomycin-intermediate Staphylococcus aureus.","volume":"50","author":"Cui","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.3201\/eid2206.151709-201605110930-R23","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s10096-013-1949-y","article-title":"Trends in the susceptibility of methicillin-resistant Staphylococcus aureus to nine antimicrobial agents, including ceftobiprole, nemonoxacin, and tyrothricin: results from the tigecycline in vitro surveillance in Taiwan (TIST) study, 2006\u20132010.","volume":"33","author":"Chen","year":"2014","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"key-10.3201\/eid2206.151709-201605110930-R24","doi-asserted-by":"publisher","first-page":"O730","DOI":"10.1111\/1469-0691.12498","article-title":"hVISA and MRSA endocarditis: an 8-year experience in a tertiary care centre.","volume":"20","author":"Maor","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"key-10.3201\/eid2206.151709-201605110930-R25","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.ijantimicag.2008.05.020","article-title":"In vitro activity of daptomycin against Gram-positive cocci: the first multicentre study in Greece.","volume":"32","author":"Malli","year":"2008","journal-title":"Int J Antimicrob Agents"},{"key":"key-10.3201\/eid2206.151709-201605110930-R26","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.diagmicrobio.2009.09.017","article-title":"Antimicrobial activity of daptomycin tested against Staphylococcus aureus with vancomycin MIC of 2 microg\/mL isolated in the United States and European hospitals (2006\u20132008).","volume":"66","author":"Sader","year":"2010","journal-title":"Diagn Microbiol Infect Dis"},{"key":"key-10.3201\/eid2206.151709-201605110930-R27","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1128\/AAC.44.4.1062-1066.2000","article-title":"In vitro activities of daptomycin, vancomycin, linezolid, and quinupristin-dalfopristin against staphylococci and enterococci, including vancomycin-intermediate and -resistant strains.","volume":"44","author":"Rybak","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.3201\/eid2206.151709-201605110930-R28","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1086\/605636","article-title":"Development of reduced vancomycin susceptibility in methicillin-susceptible Staphylococcus aureus.","volume":"49","author":"Pillai","year":"2009","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid2206.151709-201605110930-R29","doi-asserted-by":"publisher","first-page":"2687","DOI":"10.1128\/AAC.49.7.2687-2692.2005","article-title":"Reduced susceptibility of Staphylococcus aureus to vancomycin and platelet microbicidal protein correlates with defective autolysis and loss of accessory gene regulator (agr) function.","volume":"49","author":"Sakoulas","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.3201\/eid2206.151709-201605110930-R30","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1086\/596511","article-title":"Reduced susceptibility to vancomycin influences pathogenicity in Staphylococcus aureus infection.","volume":"199","author":"Peleg","year":"2009","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid2206.151709-201605110930-R31","doi-asserted-by":"publisher","first-page":"4226","DOI":"10.1128\/AAC.00160-15","article-title":"Staphylococcus aureus metabolic adaptations during the transition from a daptomycin susceptibility phenotype to a daptomycin nonsusceptibility phenotype.","volume":"59","author":"Gaupp","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.3201\/eid2206.151709-201605110930-R32","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.ijantimicag.2013.07.010","article-title":"High vancomycin minimum inhibitory concentrations with heteroresistant vancomycin-intermediate Staphylococcus aureus in methicillin-resistant S. aureus bacteraemia patients.","volume":"42","author":"Wang","year":"2013","journal-title":"Int J Antimicrob Agents"},{"key":"key-10.3201\/eid2206.151709-201605110930-R33","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1093\/cid\/civ583","article-title":"Intra- and interinstitutional evaluation of an E-test for vancomycin minimum inhibitory concentration measurement in Staphylococcus aureus blood isolates.","volume":"61","author":"Falc\u00f3n","year":"2015","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid2206.151709-201605110930-R34","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1089\/mdr.2014.0059","article-title":"The effect of inoculum size on selection of in vitro resistance to vancomycin, daptomycin, and linezolid in methicillin-resistant Staphylococcus aureus.","volume":"20","author":"Rio-Marques","year":"2014","journal-title":"Microb Drug Resist"},{"key":"key-10.3201\/eid2206.151709-201605110930-R35","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s10096-007-0455-5","article-title":"High rate of decreasing daptomycin susceptibility during the treatment of persistent Staphylococcus aureus bacteremia.","volume":"27","author":"Sharma","year":"2008","journal-title":"Eur J Clin Microbiol Infect Dis"}],"container-title":["Emerging Infectious Diseases"],"original-title":[],"link":[{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/22\/6\/15-1709_article","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T23:26:56Z","timestamp":1732922816000},"score":1,"resource":{"primary":{"URL":"http:\/\/wwwnc.cdc.gov\/eid\/article\/22\/6\/15-1709_article.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6]]}},"URL":"https:\/\/doi.org\/10.3201\/eid2206.151709","relation":{},"ISSN":["1080-6040","1080-6059"],"issn-type":[{"value":"1080-6040","type":"print"},{"value":"1080-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6]]}}}